MedTrace Logo

An Evaluation of Virtual Psychiatric Transition of Care Offered in Behavioral Health

NCT05460078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7526

Last updated 2024-10-15

Study results available
· View outcomes & findings →

Summary

The primary objective is to evaluate the effectiveness of a post inpatient discharge virtual psychiatric care team compared to standard care, to reduce 30-day all cause non-elective acute care utilization (Emergency Department (ED), observation, and inpatient encounters).

Conditions

  • Mental Health Issue

Interventions

BEHAVIORAL

Virtual Psychiatric Transition of Care Program

Behavioral Health facility or units that have discharged patients meeting inclusion criteria will be randomly assigned as either an intervention or standard care site. Intervention sites will be those using the VPTC program. This evaluation design will integrate into current workflows for the measurement of outcomes. Prior to discharge, patients may be referred to the VPTC program if they report residency or shelter in North Carolina, are 18 years of age or older on the day of discharge and can access virtual care (phone/video). The VPTC program is defined by: * Psychiatric consultation * Medication management services with pharmacological consultation * following of Health Coaching participation and provide treatment recommendations * Tracking of behavioral health symptoms and provide treatment recommendations * Health coaching; Psychoeducational support * Treatment and safety planning * Assistance connecting with an outpatient care provider

Sponsors & Collaborators

  • The Duke Endowment

    collaborator OTHER

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Jason Roberge, PhD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-08-22
Completion
2023-10-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05460078 on ClinicalTrials.gov